NCT05952934View on ClinicalTrials.gov

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2029

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
BIOLOGICAL

0.5 mL Candin®/injection

Candin or placebo injection every 3 weeks until 4 injections then every 3 months until a total of 7 injections.

OTHER

Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)

Placebo injection every 3 weeks until 4 injections then every 3 months until a total of 7 injections.

Trial Locations (6)

10016

RECRUITING

Perlmutter Cancer Center at NYU Langone Health, New York

11501

RECRUITING

Perlmutter Cancer Center at NYU Langone Health, Mineola

72205

RECRUITING

University of Arkansas for Medical Sciences, Little Rock

72762

RECRUITING

Highlands Oncology Group, PA, Fayetteville

RECRUITING

Highlands Oncology Group, PA, Springdale

75758

RECRUITING

Highlands Oncology Group, PA, Rogers

All Listed Sponsors
collaborator

Highlands Oncology Group, PA

UNKNOWN

collaborator

NYU Langone Health

OTHER

lead

University of Arkansas

OTHER